List of works - Ignasi Rodríguez-Pintó

14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome

scientific article published on 20 March 2014

A new molecular classification to drive precision treatment strategies in primary Sjögren's syndrome

scientific article published on 10 June 2021

Catastrophic APS in the context of other thrombotic microangiopathies

scientific article

Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry

scientific article published on 15 September 2016

Catastrophic antiphospholipid syndrome - 20 years later

scientific article published in January 2013

Catastrophic antiphospholipid syndrome: The current management approach

scientific article published on April 2016

Catastrophic antiphospholipid syndrome: an orchestra with several musicians

scientific article published on 01 September 2014

Catastrophic antiphospholipid syndrome: an update

scientific article published on 8 May 2017

Development and validation of a risk calculator to differentiate flares from infections in systemic lupus erythematosus patients with fever

scientific article

Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study

scientific article

Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from the "CAPS Registry".

scientific article published on 19 October 2013

Peripheral nervous system involvement in systemic lupus erythematosus: Prevalence, clinical and immunological characteristics, treatment and outcome of a large cohort from a single centre

scientific article published on 5 May 2017

Plasma exchange in catastrophic antiphospholipid syndrome

scientific article published on 04 November 2019

Precision medicine and the antiphospholipid syndrome: what is the future?

scientific article published on 15 February 2020

Relapsing catastrophic antiphospholipid syndrome potential role of microangiopathic hemolytic anemia in disease relapses

scientific article published on 10 July 2012

Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab

scientific article published on 15 June 2013

The H1 haplotype of the endothelial protein C receptor protects against arterial thrombosis in patients with antiphospholipid syndrome

scientific article published on 04 July 2018

The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review

scientific article published on 18 May 2018

The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients

scientific article published in July 2018

The problems and pitfalls in systemic lupus erythematosus drug discovery

scientific article published on 05 May 2016

Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritis.

scientific article published on 30 October 2013

[Native valve endocarditis due to Staphylococcus aureus]

scientific article published on 27 June 2012

List of works by Ignasi Rodríguez-Pintó

14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome

A new molecular classification to drive precision treatment strategies in primary Sjögren's syndrome

Catastrophic APS in the context of other thrombotic microangiopathies

Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry

Catastrophic antiphospholipid syndrome - 20 years later

Catastrophic antiphospholipid syndrome: The current management approach

Catastrophic antiphospholipid syndrome: an orchestra with several musicians

Catastrophic antiphospholipid syndrome: an update

Development and validation of a risk calculator to differentiate flares from infections in systemic lupus erythematosus patients with fever

Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study

Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from the "CAPS Registry".

Peripheral nervous system involvement in systemic lupus erythematosus: Prevalence, clinical and immunological characteristics, treatment and outcome of a large cohort from a single centre

Plasma exchange in catastrophic antiphospholipid syndrome

Precision medicine and the antiphospholipid syndrome: what is the future?

Relapsing catastrophic antiphospholipid syndrome potential role of microangiopathic hemolytic anemia in disease relapses

Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab

The H1 haplotype of the endothelial protein C receptor protects against arterial thrombosis in patients with antiphospholipid syndrome

The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review

The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients

The problems and pitfalls in systemic lupus erythematosus drug discovery

Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritis.

[Native valve endocarditis due to Staphylococcus aureus]